ASH 2013 info

Primary Viewpoints: Immunizations with Dr Steven P. Furr

People with hypertension who adhered to the mobile app demonstrated well-controlled blood pressure over a 12-week observational period.

Keith A. Reynolds

October 1st 2024

CagriSema Leads to Weight Reduction of Approximately 23% in Phase 3 REDEFINE 1 Clinical Trial, Short of the 25% Expected

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

CagriSema Leads to Weight Reduction of Approximately 23% in Phase 3 REDEFINE 1 Clinical Trial / image credit ©JHVE photo/stock.adobe.com

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The 22.7% weight loss at 68 weeks places CagriSema essentially on par with, not superior to, competing antiobesity drugs including Lilly's tirzepatide.

October 25th 2023

Women are at Higher Genetic Risk for PTSD than Men, According to Large Twin-Sibling Study

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Women at higher risk for PTSD than men, according to large twin-sibling study / image credit ©Microgen/stock.adobe.com

Targeted Intervention Boosts Colorectal Cancer Screening Rates among US Adults

In the largest twin-sibling study to date of the inherited biological risk of PTSD, researchers found additive genetic and unique environmental effects contributed to the disorder.

Smartphone App Shows Promise for Managing Hypertension in Observational Study

A centralized mailed FIT outreach intervention significantly improved CRC screening in a diverse patient population, according to recent data

Related Content

Primary Viewpoints: Immunizations with Dr Steven P. Furr

People with hypertension who adhered to the mobile app demonstrated well-controlled blood pressure over a 12-week observational period.

Keith A. Reynolds

October 1st 2024

CagriSema Leads to Weight Reduction of Approximately 23% in Phase 3 REDEFINE 1 Clinical Trial, Short of the 25% Expected

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The 22.7% weight loss at 68 weeks places CagriSema essentially on par with, not superior to, competing antiobesity drugs including Lilly's tirzepatide.

October 25th 2023

Women are at Higher Genetic Risk for PTSD than Men, According to Large Twin-Sibling Study

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Targeted Intervention Boosts Colorectal Cancer Screening Rates among US Adults

In the largest twin-sibling study to date of the inherited biological risk of PTSD, researchers found additive genetic and unique environmental effects contributed to the disorder.